ReviewDrugs2010

Trastuzumab: A review of its use as adjuvant treatment in human epidermal growth factor receptor 2 (HER2)-positive early breast cancer.

Karly P Garnock-Jones et al.PubMed ↗Publisher ↗

No numbers read from the abstract.